SCHEMBL23726723

SCHEMBL23726723

CCOC(=O)C(C)OC(=O)C1(C(F)(F)F)CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1684094 0.84 OPRM1 (0.48) OPRM1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL1282441 0.82 OPRM1 (0.47) OPRM1KMT2A
SCHEMBL23727554 0.81 OPRM1 (0.40) OPRM1
SCHEMBL23727470 0.80 OPRM1 (0.41) OPRM1KMT2A
SCHEMBL23727000 0.78 OPRM1 (0.40) OPRM1
SCHEMBL23726657 0.78 OPRM1 (0.40) OPRM1
SCHEMBL9313190 0.71 DGAT1 (0.41) OPRM1
Hydrochloric Acid SCHEMBL23727124 0.71 DGAT1 (0.37) OPRM1KMT2A
SCHEMBL21937394 0.69 DGAT1 (0.34) OPRM1KMT2A
SCHEMBL1255240 0.69 SMN1; SMN2 (0.41) OPRM1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116034107-A Quinuclidinone analogs as anticancer agents 新波制药有限公司 2023-04-28 CN disclosed
EP-4100407-A1 QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS Newave Pharmaceutical Inc. (US) 2022-12-14 EP disclosed
WO-2021158948-A1 QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS NEWAVE PHARMACEUTICAL INC. (US) 2021-08-12 WO disclosed